Scientists have launched a new study that will investigate whether poo transplants could cut the risk of serious complications from advanced liver disease.  The exciting research may also have important implications for global health as it could tackle antibiotic resistance. The unique study, funded by the National Institute of Health Research, is being unveiled in the Houses of Parliament today. At the event MPs, policy makers and senior figures from the WHO will hear from leading scientists how capsules containing bacteria from a healthy donor’s stool – known as Faecal Microbiota Transplants (or poo transplants) – to people with liver disease can clear up infections that are resistant to antibiotics. Stephen McPartland MP, who is hosting the event in parliament, said, “The Lancet published findings in 2022 that drug-resistant infections are now a leading cause of death worldwide, with 1.27 Million alone in 2019. The UK has the potential to be a world leader in this important area. We need politicians to ensure that there is appropriate investment and a national treatment infrastructure so that this important research and other similar studies can continue. “ Professor Debbie Shawcross, Clinician Scientist and Professor of Hepatology and Chronic Liver Failure at King’s … Continue reading Poo transplants could be the answer to antibiotic resistance and save the lives of liver disease patients